Cargando…

Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?

BACKGROUND: Lymphadenectomy is debated in early stages endometrial cancer. Moreover, a new FIGO classification of endometrial cancer, merging stages IA and IB has been recently published. Therefore, the aims of the present study was to evaluate the relevance of the sentinel node (SN) procedure in wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballester, Marcos, Koskas, Martin, Coutant, Charles, Chéreau, Elisabeth, Seror, Jeremy, Rouzier, Roman, Daraï, Emile
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940804/
https://www.ncbi.nlm.nih.gov/pubmed/20804553
http://dx.doi.org/10.1186/1471-2407-10-465
_version_ 1782186846511431680
author Ballester, Marcos
Koskas, Martin
Coutant, Charles
Chéreau, Elisabeth
Seror, Jeremy
Rouzier, Roman
Daraï, Emile
author_facet Ballester, Marcos
Koskas, Martin
Coutant, Charles
Chéreau, Elisabeth
Seror, Jeremy
Rouzier, Roman
Daraï, Emile
author_sort Ballester, Marcos
collection PubMed
description BACKGROUND: Lymphadenectomy is debated in early stages endometrial cancer. Moreover, a new FIGO classification of endometrial cancer, merging stages IA and IB has been recently published. Therefore, the aims of the present study was to evaluate the relevance of the sentinel node (SN) procedure in women with endometrial cancer and to discuss whether the use of the 2009 FIGO classification could modify the indications for SN procedure. METHODS: Eighty-five patients with endometrial cancer underwent the SN procedure followed by pelvic lymphadenectomy. SNs were detected with a dual or single labelling method in 74 and 11 cases, respectively. All SNs were analysed by both H&E staining and immunohistochemistry. Presumed stage before surgery was assessed for all patients based on MR imaging features using the 1988 FIGO classification and the 2009 FIGO classification. RESULTS: An SN was detected in 88.2% of cases (75/85 women). Among the fourteen patients with lymph node metastases one-half were detected by serial sectioning and immunohistochemical analysis. There were no false negative case. Using the 1988 FIGO classification and the 2009 FIGO classification, the correlation between preoperative MRI staging and final histology was moderate with Kappa = 0.24 and Kappa = 0.45, respectively. None of the patients with grade 1 endometrioid carcinoma on biopsy and IA 2009 FIGO stage on MR imaging exhibited positive SN. In patients with grade 2-3 endometrioid carcinoma and stage IA on MR imaging, the rate of positive SN reached 16.6% with an incidence of micrometastases of 50%. CONCLUSIONS: The present study suggests that sentinel node biopsy is an adequate technique to evaluate lymph node status. The use of the 2009 FIGO classification increases the accuracy of MR imaging to stage patients with early stages of endometrial cancer and contributes to clarify the indication of SN biopsy according to tumour grade and histological type.
format Text
id pubmed-2940804
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29408042010-09-17 Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy? Ballester, Marcos Koskas, Martin Coutant, Charles Chéreau, Elisabeth Seror, Jeremy Rouzier, Roman Daraï, Emile BMC Cancer Research Article BACKGROUND: Lymphadenectomy is debated in early stages endometrial cancer. Moreover, a new FIGO classification of endometrial cancer, merging stages IA and IB has been recently published. Therefore, the aims of the present study was to evaluate the relevance of the sentinel node (SN) procedure in women with endometrial cancer and to discuss whether the use of the 2009 FIGO classification could modify the indications for SN procedure. METHODS: Eighty-five patients with endometrial cancer underwent the SN procedure followed by pelvic lymphadenectomy. SNs were detected with a dual or single labelling method in 74 and 11 cases, respectively. All SNs were analysed by both H&E staining and immunohistochemistry. Presumed stage before surgery was assessed for all patients based on MR imaging features using the 1988 FIGO classification and the 2009 FIGO classification. RESULTS: An SN was detected in 88.2% of cases (75/85 women). Among the fourteen patients with lymph node metastases one-half were detected by serial sectioning and immunohistochemical analysis. There were no false negative case. Using the 1988 FIGO classification and the 2009 FIGO classification, the correlation between preoperative MRI staging and final histology was moderate with Kappa = 0.24 and Kappa = 0.45, respectively. None of the patients with grade 1 endometrioid carcinoma on biopsy and IA 2009 FIGO stage on MR imaging exhibited positive SN. In patients with grade 2-3 endometrioid carcinoma and stage IA on MR imaging, the rate of positive SN reached 16.6% with an incidence of micrometastases of 50%. CONCLUSIONS: The present study suggests that sentinel node biopsy is an adequate technique to evaluate lymph node status. The use of the 2009 FIGO classification increases the accuracy of MR imaging to stage patients with early stages of endometrial cancer and contributes to clarify the indication of SN biopsy according to tumour grade and histological type. BioMed Central 2010-08-30 /pmc/articles/PMC2940804/ /pubmed/20804553 http://dx.doi.org/10.1186/1471-2407-10-465 Text en Copyright ©2010 Ballester et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ballester, Marcos
Koskas, Martin
Coutant, Charles
Chéreau, Elisabeth
Seror, Jeremy
Rouzier, Roman
Daraï, Emile
Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
title Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
title_full Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
title_fullStr Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
title_full_unstemmed Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
title_short Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
title_sort does the use of the 2009 figo classification of endometrial cancer impact on indications of the sentinel node biopsy?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940804/
https://www.ncbi.nlm.nih.gov/pubmed/20804553
http://dx.doi.org/10.1186/1471-2407-10-465
work_keys_str_mv AT ballestermarcos doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy
AT koskasmartin doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy
AT coutantcharles doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy
AT chereauelisabeth doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy
AT serorjeremy doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy
AT rouzierroman doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy
AT daraiemile doestheuseofthe2009figoclassificationofendometrialcancerimpactonindicationsofthesentinelnodebiopsy